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Liao et al. (2015) recently reported on the effects of disrupting DNA methyltransferase activity in human
embryonic stem cells (hESCs). This work highlights key differences between mammalian ESC models
upon the loss of these essential proteins and provides comprehensive base resolution methylome maps
of DNMT targets during human development.Cytosine DNA methylation is a heritable
chemical modification of the DNA mole-
cule, predominantly associated with tran-
scriptional repression and essential for
mammalian development. In mammals,
the DNA methylation mark is deposited
and maintained through cell division by
the family of DNA methyltransferase
(DNMT) enzymes. The major mammalian
DNMT family members are DNMT1,
required for maintenance of DNA
methylation through genome replication,
and DNMT3A/DNMT3B, which generally
perform de novo DNA methylation (Ju-
rkowska et al., 2011). Interestingly, over-
laps in functionality have been reported
between DNMT1 and DNMT3 enzymes.
A new study by Liao et al. (2015) ad-
dresses how the precise targeted ablation
of these proteins’ functions affects the
differentiation capacity of human embry-
onic stem cells (hESCs) and highlights
the different effects of DNMT disruption
between mouse and human ESCs.
In their study, Liao et al. employed
the CRISPR/Cas9 genome editing sys-
tem to systematically disrupt the cata-
lytic domain of DNMT1, DNMT3a,
and DNMT3b proteins in an hESC
line, HUES64. They demonstrate that
the DNMT3A/; DNMT3B/ double
knockout cells are fully viable and able
to differentiate into all the three germ
layers (ectoderm, endoderm, and meso-
derm) as assessed by both in vitro and
in vivo assays (Figure 1). This is consistent
with previous studies undertaken in
mouse ESCs (mESCs), where single
DNMT3A or DNMT3B knockouts were
able to successfully differentiate
into erythroid and myeloid lineages
and form teratomas (Chen et al., 2003;Jackson et al., 2004). However,
mouse DNMT3A/; DNMT3B/ double
knockout ESCs only displayed full differ-
entiation capacity at earlier passages
due to the progressive loss of methylation
that affected later cultures (Jackson
et al., 2004). This lack of differentiation
potential does not appear to hold true
for DNMT3A/or DNMT3B/ hESCs,
which were able to form teratomas and
embryoid bodies even at later passages,
despite reduced DNA methylation levels.
However, perhaps themost striking differ-
ence between mESCs and hESCs is the
hESC-specific sensitivity toward the loss
of DNMT1 activity (Figure 1). While Liao
et al. were not able to obtain DNMT1/
hESC clones despite the high efficiency
of DNMT1+/ heterozygous line genera-
tion, this requirement appears to be ab-
sent from mESCs, which surprisingly can
be propagated in the absence of all three
examined DNMTs (Tsumura et al., 2006).
To further corroborate these interesting
findings, Liao et al. applied an alternative,
TALEN-based genome editing strategy
that displayed the same inability to
generate a DNMT1/ hESC line. Conse-
quently, to create a DNMT1/ hESC
line that would not result in immediate
lethality, the authors designed an elegant
rescue approach by introducing a
doxycycline-responsive (Tet-Off) DNMT1
cassette in hESCs before targeting the
endogenous sequence by the CRISPR/
Cas9 genome editing system. This re-
sulted in the creation of a stable line that
proliferated normally so long as the exog-
enous DNMT1 cassette was being ex-
pressed. Addition of doxycycline caused
rapid downregulation of the exogenous
DNMT1 and resulted in subsequent cellCell Stem Cedeath, thereby confirming the DNMT1
requirement for hESC viability.
To interrogate the effects of DNMT
function loss on the hESC DNA methyl-
ome, Liao et al. combined their powerful
knockout model system with base reso-
lution methylation profiling techniques.
Whole-genome bisulfite sequencing
of DNMT3A/, DNMT3B/, and
DNMT3A/; DNMT3B/ cells allowed
the identification of genomic targets spe-
cific to each DNMT3 protein. Whereas the
majority of low CpG-density genomic
regions appeared to be redundantly regu-
lated by both DNMT3A and DNMT3B, re-
gions of high CpG density such as CpG
islands displayed preference for either
DNMT3A or DNMT3B. Those CpG islands
were enriched for Polycomb repressive
complex 2 (PRC2) component binding
sites such as SUZ12 and EZH2, a his-
tone-lysine N-methyltransferase respon-
sible for the deposition of H3K27me3.
This suggests that a subset of regions
targeted by DNMT3A or DNMT3B and
hypermethylated in hESCs likely lose
methylation during differentiation and
become targets for Polycomb regulation.
This is consistent with previous studies
describing the cross-talk between DNA
methylation and H3K27me3 and the
mutual exclusivity of these marks on CpG
islands in mESCs (Brinkman et al., 2012).
Liao et al. also explored the perturbations
of CH methylation, a previously described
hallmark of hESCs (Ramsahoye et al.,
2000), and confirmed that DNMT3A and
DNMT3B are required for the propagation
of this atypical methylation signature, with
DNMT3A/; DNMT3B/ cells displaying
a rapid loss of CH methylation that was
not observed in the doxycycline-inducedll 16, May 7, 2015 ª2015 Elsevier Inc. 459
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Figure 1. Differentiation Potential of hESC DNMT Mutant Lines
DNMT1 is essential for hESC viability, and disruption of DNMT1 in hESCs
causes immediate cell death. Both DNMT3A and DNMT3B are dispensable
for hESC maintenance and differentiation as exemplified by embryoid body
(EB) and teratoma formation in DNMT3A/, DNMT3B/, and DNMT3A/;
DNMT3B/ mutant lines.
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investigate the effects of
DNMT loss on the generation
of a defined cell lineage, Liao
et al. took full advantage of
their in vitro differentiation sys-
tem and derived definitive
endoderm lineages from wild-
type and DNMT3A/cells,
observing a loss of DNA
methylation in promoters and
gene bodies of these cells,
thereby exposing unique ac-
tivities of DNMT3A during
endoderm differentiation.
In their current study Liao
et al. provide a powerful sys-
tem for modeling the loss of
DNMT enzymes during early
stages of human develop-
ment and describe unique
epigenomic footprints spe-
cific to each DNMT enzyme.Such studies in hESC systems are highly
informative given that targeted disruption
of these processes cannot be conducted
during human embryogenesis. However,
to date it is unclear how different culture
conditions of hESCs affect the molecular
phenotypes observed upon the loss of
DNA methylation machinery compo-
nents. Recent studies in mESCs cultured
in naive conditions suggest a highly
distinct DNA methylome configuration of
such cells (Habibi et al., 2013). It will be
interesting to see whether the observed
DNMT phenotypes can be recapitulated
in naive hESCs, as the cell lines currently
used by Liao et al. correspond to a some-
what more mature, epiblast state. Liao
et al. also propose an enticing alternative
hypothesis that can potentially explain
some differences in DNMT requirements
between humans and mouse. The au-
thors calculated the DNMT1 fidelity of
hESCs to be higher than that of mESCs,
which could suggest that the contribution460 Cell Stem Cell 16, May 7, 2015 ª2015 Elof DNMT3A and DNMT3B to mainte-
nance DNMT activity is reduced when
compared to mESCs. Nevertheless,
intriguing parallels can be drawn between
the current ESC work and insights
obtained from vertebrate embryos. The
global loss of DNA methylation in the
early mammalian embryo (Smith et al.,
2012), together with the reduced repres-
sion potential of DNA methylation during
blastula stages of Xenopus embryogen-
esis (Bogdanovic et al., 2011), suggests
reduced requirements for DNA methyl-
ation during vertebrate pluripotency.
These insights are effectively mirrored in
hESCs by the current study of Liao
et al. where the hESCs lacking both
DNMT3 enzymes can still differentiate
into all three germ layers, in addition to
previous work undertaken in mESCs
(Chen et al., 2003; Jackson et al., 2004;
Liao et al., 2015). The pioneering work
by Liao et al. provides an important foun-
dation for future studies that will aim tosevier Inc.explore how the loss of
DNMTs affects differentiation
of hESCs into different human
lineages and examine the
molecular targets of different
DNMT enzymes during such
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